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Effects of administration of estradiol-17P on the
serum and anterior pituitary IGF system in pigs
L.A. Rempel and J.A. Clapper
Department of Animal and Range Sciences

SDSU

SWINE 2001-17

The anterior pituitary (AP) gland functions as
a storage and releasing unit for several
hormones; growth hormone (GH), gonadotropins
(luteinizing hormone and follicle stimulating
hormone),
prolactin,
adrenocorticotropin
hormone, and thyroid stimulating hormone.
Luteinizing hormone (LH) functions to increase
ovarian follicular growth and maturation and
responds to increasing concentrations of
estradiol-17P (E2 ) that occur at estrus to cause
ovulation.
Production and secretion of the
protein, insulin-like growth factor-I (IGF-1),
occurs primarily in the liver, in response to GH
release from the anterior pituitary gland. Insulinlike growth factor-I increases glucose uptake,
amino acid transport, and glycogen synthesis
resulting in increased protein accretion.
Mitogenic effects of IGF-1 can be manifested by
increases in DNA, RNA, and protein.
Furthermore, IGF-1 stimulates differentiation at
low levels usually preceding a mitogenic
response. The biological effects of IGF-1 are
mediated by it's interaction with the IGF type I
receptor and modulated by IGF binding proteins
(IGFBPs). Insulin-like growth factor:1, IGFBPs,
and IGF receptors have been detected in the AP
gland of several species and may exert
regulatory effects at the hypothalamichypophyseal level affecting gonadotropins, and
in turn, reproductive performance.

have been noted throughout the bovine estrous
cycle.
Extended treatment of steers with
exogenous estradiol resulted in increased serum
concentrations of IGF-1.
Simpson and coworkers found that treating ovariectomized cows
with estradiol for 45 days increased pituitary
gland weight and resulted in greater plasma
concentrations of IGF-1 and total plasma IGFBP
activity compared to control cows.

There is evidence to suggest that estrogens
can increase serum and AP concentrations of
IGF-1 as well as expression of certain IGFBPs
within the AP gland. Previous research has
demonstrated that fluctuations in components of
the IGF system can influence gonadotroph
function. Addition of IGF-1 to dispersed AP cells
obtained from gilts in either the follicular or luteal
phase of the estrous cycle increased
gonadotropin
releasing
hormone (GnRH)
stimulated LH secretion over that in cells treated
with no IGF-1.
Studies have shown that
administration of E2 to pituitary tumor cells
increases production of IGF-1 and IGFBP-3.
Changes in relative amounts of pituitary IGFBPs

The AP IGF system in swine has not been
well defined. The effects of E2 on AP function
may be partially explained by changes in
components of the IGF system. A thorough
understanding of the porcine AP IGF system, is
a necessary first step .in developing strategies to
control
pituitary function
that
enhance
reproduction and growth. Improved reproductive
and growth performance will ultimately have a
positive economic impact on the producer.

Steroid implants have long been used in
cattle to improve growth and performance. By
using such implants producers have improved
feed efficiency and decreased feed costs, thus
increasing their profitability. Use of E2 and
trenbolone acetate (TBA) implants elicited an
increase in circulating levels of IGF-1 stimulating
muscle growth in crossbred yearling steers.
Wethers treated with E2 and TBA also had
increased serum concentrations of IGF-1 and
had improved average daily gain and feed
efficiency.
Research has shown that boars
produce and secrete greater amounts of E2 , of
testicular origin, and produce leaner carcasses
than gilts or barrows. A study conducted in our
lab with prepubertal boars, found that rising
serum concentrations of IGF-1 paralleled rising
serum concentrations of E2 . Similarly, feed
efficiency was greater in boars than in gilts or
barrows (castrated males.).

We performed a preliminary study to
determine if administration of E2 implants
(25. 7 mg E2 ) could elevate serum concentrations
of E2 in barrows similar to that of boars of
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Three groups of pigs were randomly allotted by
litter; boars (n=11 ), non-implanted barrows (n=12),
and E2 implanted barrows (n=9). All pigs were
penned individually throughout the experiment.
Implanted barrows were administered two E2
implants (25.7 mg E2 ,each) subcutaneously at the
base of each ear on d 1. Blood samples, body
weight, and feed disappearance was collected
every two weeks thereafter and at slaughter (d 90).

comparable age and maturity and subsequently
affect the AP IGF system.
Twenty crossbred
barrows were randomly assigned by litter to one of
four treatment groups .of five barrows each.
Treatment groups were as follows; 1) two implants,
2) three implants, 3) four implants, and 4) no
implants.
This preliminary study determined that
administration of E2 implants elevated serum
concentrations of E2 in barrows over a 35-day
period similar to what is found in gonadally intact
boars of comparable age.
Mean serum
concentrations of E2 for barrows receiving 0, 2, 3, or
4 implants were 11.7, 58.6, 78.3, and 87.4 pg/ml,
respectively. Anterior pituitary concentrations of
IGF-1 were increased (P<.05) by implantation with
E2 versus no implant (623.2 ± 73.8 ng/ml versus
208.2 ± 73.8 ng/ml, respectively.)
Serum
concentrations of IGF-1 were also increased (P<.05)
in implanted barrows versus non-implanted from
day 7 through day 35 of the experiment. Mean
serum concentrations of IGF-1 in implanted barrows
were 196.4 ± 10.3 ng/ml compared to 141.1 ±
10.3 ng/ml in barrows without implants. Implant
effects on serum IGF-1 levels were not dose
dependent (P>.05). Feed efficiency, measured by
G/F ratios, was greater (P<.05) in implanted
animals versus those without implants.
Feed
efficiency of barrows with zero and two implants
was not different (P> .05), whereas, barrows with
three and four implants had an improved (P<.05)
feed efficiency compared to controls, but were not
different from barrows with two implants (P> .05).

Chronic administration of E2 to barrows
increased (P<.05) serum concentrations of E2 in
implanted barrows versus boars.
Serum
concentrations of T increased (P<.05) over time in
the boars from d O to d 90. Administration of E2 to
implanted
barrows
increased
(P<.05)
AP
concentrations of IGF-1 compared to boars and nonimplanted barrows, ·but had no affect (P> .05) on
relative ,amounts of serum and AP IGFBPs. Mean
serum concentrations of IGF-1 tended to be- greater
(P=.08) in implanted barrows versus non-implanted
barrows. Gain to feed ratios increased in the
implanted barrows versus control barrows, but
boars grew more efficiently than implanted barrows.
In collaboration with Dr. Andy Roberts at the Meat
Animal Research Center in Clay Center, Nebraska,
we were able to identify two IGFBPs in the AP
gland,
IGFBP-2
and ·
-5,
through
immunoprecipitation. Relative amounts of each of
these AP IGFBPs were greater (P<.05) in boars
than either barrows with or without E2 implants. To
date, no one has published such a find in the
porcine pituitary gland.
Estradiol is believed to have a great impact on
the IGF system in ruminant animals. Ourwork has
led us to conclude that E2 plays a primary role in
the porcine AP IGF system. The use of E2 in the
barrow allowed us to use a model with levels of
endogenous E2 at nearly zero. However, at the
same time we eliminated other testicular hormones
and factors.
Our study implies that the boar
produces and secretes other hormones and factors
that could work synergistically or additively in the
regulation of the AP IGF system.
Analyses
presently being conducted include the quantification
of expression for IGF-1, IGF-1 receptor, and IGFBPs,
to substantiate our hypothesis that E2 upregulates
components of the porcine AP IGF system.
Furthermore, our lab will also determine if AP
concentrations o( IGF-1 are related to expression of
GnRH receptor, a sub-unit, and LH 13 and FSH 13
sub-units.

Our preliminary work indicated that E2 does
regulate the IGF system in swine. Both serum and
AP concentrations of IGF-1 were increased after
administration of E2 • These data suggest that boars
and gilts, which naturally produce E2 , have greater
serum and AP concentrations of IGF-1 and may
influence growth and reproductive performance.
Further investigations are required to determine if
boars and gilts have similar responses to
endogenous E2 •
A second experiment was designed to
determine if administration of E2 to barrows
increases components of the IGF system to levels
similar to that found in boars of similar age and
weight.
Hypophyseal concentrations of IGF-1,
serum concentrations of E2 and IGF-1, relative
amounts of serum and AP IGFBPs, and
concentrations of AP LH and GH were analyzed in
barrows after administration of E2 and compared to
boars and nonaimplanted barrows.
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